. 2007 Aug 16;98(11):1790–1794. doi: 10.1111/j.1349-7006.2007.00590.x

Table 2.

TLR2 polymorphism and risk of gastric cancer (compared with healthy control subjects)

Variable	TLR2 genotype (%)			OR (95% CI) ins/ins vs ins/del	P‐value	OR (95% CI) ins/ins vs del carriers	P‐value	OR (95% CI) del/del vs others	P‐value
Variable	ins/ins	ins/del	del/del	OR (95% CI) ins/ins vs ins/del	P‐value	OR (95% CI) ins/ins vs del carriers	P‐value	OR (95% CI) del/del vs others	P‐value
Healthy control subjects (n = 146)	73 (50.0)	65 (44.5)	8 (5.5)	Reference		Reference		Reference
NCGC (n = 289)	126 (43.6)	112 (38.8)	51 (17.6)	1.00 (0.66–1.52)	1	1.29 (0.87–1.93)	0.22	3.70 (1.70–8.02) ^†	0.0009 ^†

^{^†}

Age, sex‐adjusted OR = 6.06 (95% CI = 1.86–19.72), P = 0.003. Statistical significance was assessed using the two‐sided Fisher's exact test. CI, confidence interval; del carriers, ins/del + del/del; NCGC, non‐cardiac gastric cancer; OR, odds ratio.